NeuroBo Pharmaceuticals, Inc. (NRBO)
USD 2.36
(N/A%)
USD 2.36
(N/A%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | 28 Thousand | 72 Thousand | 67 Thousand | 17 Thousand | - |
| Gross Profit | - | -28 Thousand | -72 Thousand | -67 Thousand | -17 Thousand | - |
| Operating Expenses | 15.88 Million | 11.41 Million | 15.29 Million | 29.71 Million | 20.17 Million | 22.8 Million |
| Selling, General and Administrative Expenses | 6.72 Million | 8.64 Million | 8.75 Million | 7.84 Million | 2.7 Million | 8.49 Million |
| Research and Development Expenses | 9.15 Million | 2.77 Million | 6.54 Million | 21.87 Million | 17.47 Million | 14.31 Million |
| Other Expenses | - | -83 Thousand | - | -1000.00 | 12.15 Million | -178 Thousand |
| Cost and Expenses | 15.88 Million | 11.41 Million | 15.29 Million | 29.71 Million | 20.17 Million | 22.8 Million |
| Operating Income | -15.88 Million | -19.62 Million | -15.29 Million | -29.71 Million | -20.17 Million | -22.8 Million |
| Interest Expense | - | 2.19 Million | - | 39 Thousand | 22 Thousand | 654 Thousand |
| Income Tax Expense | - | -7.85 Million | -62 Thousand | -85 Thousand | 1.11 Million | 654 Thousand |
| Earnings before Tax | -12.47 Million | -13.96 Million | -15.28 Million | -29.67 Million | -21.31 Million | -23.63 Million |
| Net Income | -12.47 Million | -6.11 Million | -15.22 Million | -29.59 Million | -22.43 Million | -23.63 Million |
| Earnings Per Share Basic | -2.46 | -19.01 | -157.85 | -437.95 | -1030.50 | -166.80 |
| Earnings Per Share Diluted | -2.46 | -19.01 | -157.85 | -437.95 | -1030.50 | -166.80 |
| Weighted Average Shares Outstanding | 5.06 Million | 321.7 Thousand | 96.43 Thousand | 67.57 Thousand | 21.76 Thousand | 141.71 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 5.07 Million | 321.7 Thousand | 96.43 Thousand | 67.57 Thousand | 21.76 Thousand | 141.71 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -15.88 Million | -11.39 Million | -15.21 Million | -29.61 Million | -21.16 Million | -15.48 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 7000.00 | 4000.00 | - | - |
| Cost of Revenue | 6000.00 | 4000.00 | 7000.00 | 4000.00 | 1000.00 | - |
| Gross Profit | -6000.00 | -4000.00 | - | - | -1000.00 | - |
| Operating Expenses | 10.07 Million | 6.87 Million | 15.87 Million | 5.66 Million | 3.89 Million | 3.8 Million |
| Selling, General and Administrative Expenses | 2 Million | 1.97 Million | - | 1.8 Million | 1.6 Million | 1.44 Million |
| Research and Development Expenses | 8.07 Million | 4.9 Million | - | 3.86 Million | 2.29 Million | 2.36 Million |
| Other Expenses | - | - | 7000.00 | 4000.00 | - | - |
| Cost and Expenses | 10.08 Million | 6.88 Million | 15.88 Million | 5.66 Million | 3.89 Million | 3.8 Million |
| Operating Income | -10.08 Million | -6.88 Million | -15.88 Million | -5.66 Million | -3.89 Million | -3.8 Million |
| Interest Expense | - | - | - | -84 Thousand | - | - |
| Income Tax Expense | - | -39.27 Thousand | - | -83 Thousand | -1000.00 | -3.19 Million |
| Earnings before Tax | -10.05 Million | -6.71 Million | -12.47 Million | -5.31 Million | -3.81 Million | -734 Thousand |
| Net Income | -10.05 Million | -6.71 Million | -12.47 Million | -5.31 Million | -3.81 Million | -734 Thousand |
| Earnings Per Share Basic | -1.85 | -1.32 | - | -1.05 | -0.75 | -0.15 |
| Earnings Per Share Diluted | -1.85 | -1.32 | - | -1.05 | -0.75 | -0.15 |
| Weighted Average Shares Outstanding | 5.42 Million | 5.08 Million | 5.07 Million | 5.07 Million | 5.07 Million | 5.05 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.42 Million | 5.08 Million | 5.07 Million | 5.07 Million | 5.07 Million | 5.05 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | -1415.75 | - | - |
| Profit Margin | - | - | -1781.43 | -1328.50 | - | - |
| EBITDA | -10.07 Million | -6.87 Million | - | -5.66 Million | -3.89 Million | -6.87 Million |
| Earnings Before Tax Margin | - | - | -2269.43 | -1416.75 | - | - |
HPIL
300130
AKE
TUSK
300852
CAMB3